COMMUNIQUÉS West-GlobeNewswire
-
Psychemedics Releases 2026 Education Insights Report
30/06/2026 -
Celebrate the Fourth—Without Damaging Your Hearing or Losing Your Voice
30/06/2026 -
Nelipak Healthcare Packaging receives ISCC PLUS certification for Clara, Ireland production facility
30/06/2026 -
ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel
30/06/2026 -
Imviva Biotech Receives FDA IDE Authorization for clonoSEQ® Assay in TENACITY-01 Clinical Trial
30/06/2026 -
Dogwood Therapeutics Appoints Iain Dukes, Venture Partner at OrbiMed, as Chair of Scientific Advisory Board
30/06/2026 -
Artelo Biosciences Presents Evidence for a Common Lipid-Signaling Link Across Multiple Potential Indications for Its FABP5 Inhibitor Platform at ICRS 2026
30/06/2026 -
Weight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program
30/06/2026 -
Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer
30/06/2026 -
FEATOL Rolls Out Reinforced Lower Back Brace to Help Adults During Work, Driving, and in Chronic Pain
30/06/2026 -
Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants
30/06/2026 -
Children with Achondroplasia Treated with TransCon CNP Showed Continued Improvements in Lower Extremity Alignment at Week 104 of the Pivotal ApproaCH Trial
30/06/2026 -
Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses
30/06/2026 -
New Analyses Advance Understanding of Long-Term Survival Outcomes with Mogamulizumab in Mycosis Fungoides and Sézary Syndrome
30/06/2026 -
Exicure Announces Board and Committee Changes
30/06/2026 -
Jushi Celebrates Enactment of Virginia Adult-Use Cannabis Legislation
30/06/2026 -
Flare Therapeutics Secures $85M in Insider-Led Series C Financing and Appoints Anna Protopapas as Chief Executive Officer
30/06/2026 -
Quoin Pharmaceuticals Receives U.S. Notice of Allowance for Patent Covering Combination Treatment for Netherton Syndrome
30/06/2026 -
TerrAscend Signs Agreement to Acquire Fifth Dispensary in New Jersey
30/06/2026
Pages